US Stock MarketDetailed Quotes

PharmaCyte Biotech (PMCB)

Watchlist
  • 0.7223
  • -0.0276-3.68%
Close Apr 24 15:59 ET
  • 0.7300
  • +0.0077+1.07%
Post 19:54 ET
7.75MMarket Cap-0.81P/E (TTM)

PharmaCyte Biotech (PMCB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2026
(Q2)Oct 31, 2025
(Q1)Jul 31, 2025
(FY)Apr 30, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-54.32%-786.85K
7.13%-979.52K
-434.15%-1.99M
-38.43%-2.98M
-212.46%-1.04M
-187.91%-509.89K
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
Net income from continuing operations
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
9,084.98%30.66M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
Operating gains losses
-46.72%3.13M
220.01%3.99M
122.80%5.23M
-95.73%-8.17M
565.99%12.21M
2,654.23%5.87M
-0.66%-3.33M
-1,256.97%-22.93M
---4.17M
---2.62M
Other non cash items
---515K
----
----
-10,785.50%-21.23M
---20.93M
----
----
----
-212.05%-195K
----
Change In working capital
-104.92%-20.77K
128.87%129.74K
-859.79%-954.84K
353.78%1.36M
1,343.28%1.26M
211.04%422.21K
18.98%-449.33K
-80.07%125.67K
200.58%298.89K
151.90%87.15K
-Change in prepaid assets
20.51%344.48K
-4.74%-264.97K
-173.68%-14.42K
123.69%36.04K
-143.19%-16.4K
1,024.20%285.85K
-7.87%-252.99K
2.85%19.57K
-1,026.06%-152.12K
-48.23%37.96K
-Change in payables and accrued expense
-367.87%-365.26K
301.03%394.71K
-986.37%-940.42K
192.74%1.32M
2,490.54%1.27M
23.61%136.35K
38.66%-196.34K
-82.65%106.1K
259.00%451.01K
120.39%49.19K
Cash from discontinued investing activities
Operating cash flow
-54.32%-786.85K
7.13%-979.52K
-434.15%-1.99M
-38.43%-2.98M
-212.46%-1.04M
-187.91%-509.89K
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
Investing cash flow
Cash flow from continuing investing activities
5M
-3M
0
-40.00%-7M
0
0
0
-7M
-5M
0
Net investment purchase and sale
--0
---3M
--0
---7M
--0
--0
--0
---7M
--0
--0
Net other investing changes
----
----
----
----
----
----
----
----
---5M
--0
Cash from discontinued investing activities
Investing cash flow
--5M
---3M
--0
-40.00%-7M
--0
--0
--0
---7M
---5M
--0
Financing cash flow
Cash flow from continuing financing activities
113.78%543.78K
157.80%6.21M
0
-133.74%-25.03M
98.40%-171.54K
43.95%-3.95M
-1,534.56%-10.74M
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
Net common stock issuance
-150.74%-564.23K
--0
--0
90.98%-2.54M
85.40%-171.54K
43.84%-225.03K
-750.87%-1.4M
97.19%-742.18K
-107.94%-28.2M
72.73%-1.17M
Net preferred stock issuance
101.65%61.25K
166.49%6.21M
--0
-228.57%-22.49M
--0
43.95%-3.72M
-591.66%-9.34M
-126.94%-9.43M
--17.49M
---9.52M
Proceeds from stock option exercised by employees
----
----
----
--0
--0
--0
--0
--0
-92.05%70
--0
Cash from discontinued financing activities
Financing cash flow
113.78%543.78K
157.80%6.21M
--0
-133.74%-25.03M
98.40%-171.54K
43.95%-3.95M
-1,534.56%-10.74M
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
Net cash flow
Beginning cash position
-26.07%15.41M
-59.62%13.18M
-69.76%15.17M
-26.25%50.18M
-73.23%16.38M
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-20.33%68.04M
-15.73%61.21M
Current changes in cash
206.77%4.76M
118.89%2.23M
88.64%-1.99M
-96.02%-35.01M
89.01%-1.21M
63.53%-4.46M
-854.55%-11.8M
-364.95%-17.55M
-2.92%-17.86M
-140.04%-11.03M
Effect of exchange rate changes
312.22%2.59K
-724.59%-381
-32.79%123
29.53%-358
240.87%617
-213.93%-1.22K
103.83%61
-59.42%183
92.99%-508
91.70%-438
End cash Position
23.08%20.17M
-26.07%15.41M
-59.62%13.18M
-69.76%15.17M
-69.76%15.17M
-73.23%16.38M
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-26.25%50.18M
Free cash flow
-54.32%-786.85K
7.13%-979.52K
-434.15%-1.99M
-38.43%-2.98M
-212.46%-1.04M
-187.91%-509.89K
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Jan 31, 2026(Q2)Oct 31, 2025(Q1)Jul 31, 2025(FY)Apr 30, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -54.32%-786.85K7.13%-979.52K-434.15%-1.99M-38.43%-2.98M-212.46%-1.04M-187.91%-509.89K46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K
Net income from continuing operations 124.52%746.86K-404.78%-7.42M-135.69%-8.36M9,084.98%30.66M772.47%11.75M-391.55%-3.05M-152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M
Operating gains losses -46.72%3.13M220.01%3.99M122.80%5.23M-95.73%-8.17M565.99%12.21M2,654.23%5.87M-0.66%-3.33M-1,256.97%-22.93M---4.17M---2.62M
Other non cash items ---515K---------10,785.50%-21.23M---20.93M-------------212.05%-195K----
Change In working capital -104.92%-20.77K128.87%129.74K-859.79%-954.84K353.78%1.36M1,343.28%1.26M211.04%422.21K18.98%-449.33K-80.07%125.67K200.58%298.89K151.90%87.15K
-Change in prepaid assets 20.51%344.48K-4.74%-264.97K-173.68%-14.42K123.69%36.04K-143.19%-16.4K1,024.20%285.85K-7.87%-252.99K2.85%19.57K-1,026.06%-152.12K-48.23%37.96K
-Change in payables and accrued expense -367.87%-365.26K301.03%394.71K-986.37%-940.42K192.74%1.32M2,490.54%1.27M23.61%136.35K38.66%-196.34K-82.65%106.1K259.00%451.01K120.39%49.19K
Cash from discontinued investing activities
Operating cash flow -54.32%-786.85K7.13%-979.52K-434.15%-1.99M-38.43%-2.98M-212.46%-1.04M-187.91%-509.89K46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K
Investing cash flow
Cash flow from continuing investing activities 5M-3M0-40.00%-7M000-7M-5M0
Net investment purchase and sale --0---3M--0---7M--0--0--0---7M--0--0
Net other investing changes -----------------------------------5M--0
Cash from discontinued investing activities
Investing cash flow --5M---3M--0-40.00%-7M--0--0--0---7M---5M--0
Financing cash flow
Cash flow from continuing financing activities 113.78%543.78K157.80%6.21M0-133.74%-25.03M98.40%-171.54K43.95%-3.95M-1,534.56%-10.74M-261.99%-10.17M21.03%-10.71M-148.38%-10.7M
Net common stock issuance -150.74%-564.23K--0--090.98%-2.54M85.40%-171.54K43.84%-225.03K-750.87%-1.4M97.19%-742.18K-107.94%-28.2M72.73%-1.17M
Net preferred stock issuance 101.65%61.25K166.49%6.21M--0-228.57%-22.49M--043.95%-3.72M-591.66%-9.34M-126.94%-9.43M--17.49M---9.52M
Proceeds from stock option exercised by employees --------------0--0--0--0--0-92.05%70--0
Cash from discontinued financing activities
Financing cash flow 113.78%543.78K157.80%6.21M--0-133.74%-25.03M98.40%-171.54K43.95%-3.95M-1,534.56%-10.74M-261.99%-10.17M21.03%-10.71M-148.38%-10.7M
Net cash flow
Beginning cash position -26.07%15.41M-59.62%13.18M-69.76%15.17M-26.25%50.18M-73.23%16.38M-71.62%20.84M-56.29%32.64M-26.25%50.18M-20.33%68.04M-15.73%61.21M
Current changes in cash 206.77%4.76M118.89%2.23M88.64%-1.99M-96.02%-35.01M89.01%-1.21M63.53%-4.46M-854.55%-11.8M-364.95%-17.55M-2.92%-17.86M-140.04%-11.03M
Effect of exchange rate changes 312.22%2.59K-724.59%-381-32.79%12329.53%-358240.87%617-213.93%-1.22K103.83%61-59.42%18392.99%-50891.70%-438
End cash Position 23.08%20.17M-26.07%15.41M-59.62%13.18M-69.76%15.17M-69.76%15.17M-73.23%16.38M-71.62%20.84M-56.29%32.64M-26.25%50.18M-26.25%50.18M
Free cash flow -54.32%-786.85K7.13%-979.52K-434.15%-1.99M-38.43%-2.98M-212.46%-1.04M-187.91%-509.89K46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More